For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Marcus F Boehm

USPTO Granted Patents = 64 (Patent Applications = 18)

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 15)

Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 482(Granted Patents)

Forward Citations (Not Self Cited) = 388(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Ligand Pharmaceuticals, Inc.

Escient Pharmaceuticals, Inc.

Conforma Therapeutics Corporation

4. 10 out of 17

Celgene International II Sarl

5. 10 out of 25

6. 6 out of 576

The Salk Institute for Biological Studies

7. 4 out of 601

Baylor College of Medicine

9. 1 out of 4,447

Eli Lilly and Company

10. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Mas-Related G-Protein Receptor X2

Mas-Related G-Protein Receptor X4

GLP-1 Receptor Modulators

Sphingosine 1 Phosphate Receptor Modulators

HSP90-Inhibitors

Retinoid X Receptor Modulators

Alkynyl Pyrrolo[2,3-D]Pyrimidines

Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators

Ansamycins

Purine Analogs

Pyrazolopyrimidines

Pyrrolopyrimidines

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384748 - Modulators of mas-related g-protein receptor X2 and related products and methods (2025-08-12),

2. 12275707 - Modulators of mas-related g-protein receptor X2 and related products and methods (2025-04-14),

3. 12240845 - Modulators of mas-related G-protein receptor X2 and related products and methods (2025-03-04),

4. 12129244 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-10-29),

5. 12129243 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-10-29),

6. 11970452 - Modulators of mas-related G-protein receptor X2 and related products and methods (2024-04-30),

7. 11952346 - Modulators of mas-related G-protein receptor X2 and related products and methods (2024-04-09),

8. 11919864 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-03-05),

9. 11840521 - Modulators of Mas-related G-protein receptor X4 and related products and methods (2023-12-12),

10. 11787767 - Modulators of mas-related g-protein receptor X4 and related products and methods (2023-10-17),

11. 11667636 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2023-06-06),

12. 11643399 - Modulators of mas-related G-protein receptor X4 and related products and methods (2023-05-09),

13. 10259823 - GLP-1 receptor modulators (2019-04-16),

14. 10239846 - Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis (2019-03-26),

15. 10034886 - GLP-1 receptor modulators (2018-07-31),

Title: The Innovative Journey of Marcus F. Boehm

Introduction: Marcus F. Boehm is a visionary inventor based in San Diego, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Marcus F. Boehm holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Marcus F. Boehm has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Marcus F. Boehm has collaborated with top engineers, scientists, and researchers to bring his ideas to life, fostering a culture of innovation and excellence in all his projects.

Conclusion: Marcus F. Boehm's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technological advancements globally.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…